Intermittent oral levetiracetam preventing the recurrence of febrile seizure with epileptiform discharges under the monitoring of iThermonitor: a multicenter randomized controlled trail

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15007241

Enrollment

Unknown

Registered

2015-06-21

Start date

2015-10-31

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

febrile seizure

Interventions

A:LEV 15-30mg/kg

B:NA

Eligibility

Sex/Gender

Female

Age

1 Years to 5 Years

Inclusion criteria

Inclusion criteria: children with a history of two or more episodes of FS within the last 1 year, at least one seizure recurrence within the last 2 weeks, and onset age between 12 months and 48 months.

Exclusion criteria

Exclusion criteria: episodes of previous seizures without fever, intracranial infections or head trauma, or current use of AEDs; patients with severe liver and kidney disease, hematological disease, autoimmune disease and Chronic severe infection and so on.

Design outcomes

Primary

Measure	Time frame
seizure frequency associated with febrile events;FS recurrence rate (RR);	—

Countries

China

Contacts

Public ContactLi-Ping Zou

zouliping21@sina.com+86 10 66939770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026